Compound Genetically Engineered Mouse Models of Cancer Reveal Dual Targeting of ALK1 and Endoglin as a Synergistic Opportunity to Impinge on Angiogenic TGF-β Signaling

Oncotarget - United States
doi 10.18632/oncotarget.12604
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Genetically Engineered Mouse Models of Cancer

Science-Business eXchange
2008English

Genetically-Engineered Mouse Pancreatic Cancer Models

Suizo
2010English

Translational Therapeutics in Genetically Engineered Mouse Models of Cancer

Cold Spring Harbor Protocols
BiochemistryGeneticsMolecular Biology
2014English

Genetically Engineered ER -Positive Breast Cancer Mouse Models

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Genetically Engineered Mucin Mouse Models for Inflammation and Cancer

Cancer and Metastasis Reviews
Cancer ResearchOncology
2015English

Genetically Engineered Mouse Models of Parkinson's Disease

Brain Research Bulletin
Neuroscience
2012English

Non-Germline Genetically Engineered Mouse Models for Translational Cancer Research

Nature Reviews Cancer
Cancer ResearchOncology
2010English

CFTR Dysfunction Increases Endoglin and TGF-β Signaling in Airway Epithelia

Physiological Reports
Physiology
2019English

Abnormal Expression of Endoglin and Its Receptor Complex (TGF-β1 and TGF-β Receptor II) as Early Angiogenic Switch Indicator in Premalignant Lesions of the Colon Mucosa

International Journal of Oncology
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy